Elixinol Wellness Ltd - Asset Resilience Ratio
Elixinol Wellness Ltd (EXL) has an Asset Resilience Ratio of 0.46% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Elixinol Wellness Ltd working capital to net assets to evaluate short-term liquidity relative to the company's equity base.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2002–2025)
This chart shows how Elixinol Wellness Ltd's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see balance sheet size of Elixinol Wellness Ltd.
Liquid Assets Composition Over Time
This chart breaks down Elixinol Wellness Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore EXL long-term investment intensity to see how much of total assets are deployed in long-term investments.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | AU$0.00 | 0% |
| Short-term Investments | AU$73.00K | 0.46% |
| Total Liquid Assets | AU$73.00K | 0.46% |
Asset Resilience Insights
- Limited Liquidity: Elixinol Wellness Ltd maintains only 0.46% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Elixinol Wellness Ltd Industry Peers by Asset Resilience Ratio
Compare Elixinol Wellness Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Swedish Orphan Biovitrum AB (publ)
ST:SOBI |
Drug Manufacturers - Specialty & Generic | 1.54% |
|
Takeda Pharmaceutical Co Ltd ADR
NYSE:TAK |
Drug Manufacturers - Specialty & Generic | 4.94% |
|
Takeda Pharmaceutical Company Limited
F:TKDA |
Drug Manufacturers - Specialty & Generic | 0.69% |
|
Piramal Pharma Limited
NSE:PPLPHARMA |
Drug Manufacturers - Specialty & Generic | 0.73% |
|
Kangmei Pharmaceutical Co Ltd
SHG:600518 |
Drug Manufacturers - Specialty & Generic | 0.00% |
|
Zhejiang Medicine Co Ltd
SHG:600216 |
Drug Manufacturers - Specialty & Generic | 1.85% |
|
Shanghai Yizhong Pharmaceutical Co Ltd
SHG:688091 |
Drug Manufacturers - Specialty & Generic | 26.36% |
|
Jiangsu Kanion Pharmaceutical Co Ltd
SHG:600557 |
Drug Manufacturers - Specialty & Generic | 0.29% |
Annual Asset Resilience Ratio for Elixinol Wellness Ltd (2002–2025)
The table below shows the annual Asset Resilience Ratio data for Elixinol Wellness Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 0.46% | AU$73.00K ≈ $51.65K |
AU$15.96 Million ≈ $11.30 Million |
-0.77pp |
| 2022-12-31 | 1.23% | AU$166.00K ≈ $117.46K |
AU$13.48 Million ≈ $9.54 Million |
+0.56pp |
| 2021-12-31 | 0.67% | AU$170.00K ≈ $120.29K |
AU$25.33 Million ≈ $17.92 Million |
+0.47pp |
| 2020-12-31 | 0.20% | AU$85.00K ≈ $60.14K |
AU$42.47 Million ≈ $30.05 Million |
-16.61pp |
| 2019-12-31 | 16.81% | AU$20.35 Million ≈ $14.40 Million |
AU$121.07 Million ≈ $85.66 Million |
-11.12pp |
| 2018-12-31 | 27.93% | AU$42.92 Million ≈ $30.37 Million |
AU$153.69 Million ≈ $108.75 Million |
+9.99pp |
| 2017-12-31 | 17.94% | AU$18.83 Million ≈ $13.33 Million |
AU$105.00 Million ≈ $74.30 Million |
-- |
| 2016-12-31 | 0.00% | AU$0.00 ≈ $0.00 |
AU$103.81 Million ≈ $73.45 Million |
-- |
| 2005-12-31 | 0.33% | AU$3.19 Million ≈ $2.26 Million |
AU$963.19 Million ≈ $681.52 Million |
-0.26pp |
| 2004-12-31 | 0.59% | AU$3.61 Million ≈ $2.56 Million |
AU$609.48 Million ≈ $431.25 Million |
-0.58pp |
| 2003-12-31 | 1.18% | AU$3.81 Million ≈ $2.69 Million |
AU$323.21 Million ≈ $228.69 Million |
-0.53pp |
| 2002-12-31 | 1.71% | AU$4.00 Million ≈ $2.83 Million |
AU$234.12 Million ≈ $165.66 Million |
-- |
About Elixinol Wellness Ltd
Elixinol Wellness Limited, a holding company, produces and sells human nutrition, human wellness, pet wellness, and superfood ingredients in Australia, the Americas, and internationally. The company offers its products under Hemp Foods Australia, Mt Elephant, The Healthy Chef, Soul Foods, Ananda Equine, and Field Day brands. It distributes its products through grocery, wholesale, and e-commerce c… Read more